Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
13F holders, Q1 2025
Institutional positions in Alterity Therapeutics Ltd as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- 0 vs. Q4 2024
- Shares held
- 241.7K
- +117.4K (+94.5%) vs. Q4 2024
- Total value
- $833.9K
- +$418.1K (+100.5%) vs. Q4 2024
- New holders
- 2
- 4 more added
- Sold out
- 2
- 1 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATHE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.12M |
| Q1 2026 | 15 | $1.12M |
| Q4 2025 | 18 | $1.00M |
| Q3 2025 | 16 | $1.26M |
| Q2 2025 | 11 | $906.9K |
| Q1 2025 | 12 | $833.9K |
| Q4 2024 | 13 | $415.9K |
| Q3 2024 | 13 | $148.6K |
| Q2 2024 | 10 | $140.9K |
| Q1 2024 | 10 | $193.8K |
| Q4 2023 | 9 | $226.7K |
| Q3 2023 | 8 | $143.5K |
| Q2 2023 | 7 | $163.2K |
| Q1 2023 | 7 | $260.3K |
| Q4 2022 | 13 | $230.5K |
| Q3 2022 | 9 | $299.0K |
| Q2 2022 | 10 | $441.0K |
| Q1 2022 | 13 | $643.0K |
| Q4 2021 | 11 | $541.0K |
| Q3 2021 | 14 | $808.1K |
| Q2 2021 | 14 | $1.29M |
| Q1 2021 | 12 | $1.45M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Alterity Therapeutics Ltd; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 131,431 | $453.4K | 0.00% | +98,804+302.8% | Added |
| Morgan Stanley | 43,701 | $150.8K | 0.00% | −700−1.6% | Reduced |
| HB Wealth Management, LLC | 37,483 | $129.3K | 0.00% | +5,600+17.6% | Added |
| UBS Group AG | 13,004 | $44.9K | 0.00% | +12,620+3,286.5% | Added |
| BNP Paribas Arbitrage, SA | 9,752 | $33.6K | 0.00% | +962+10.9% | Added |
| Twin Lakes Capital Management, LLC | 5,925 | $20.4K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 181 | $626 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 130 | $450 | 0.00% | +130 | New |
| JPMorgan Chase & Co | 53 | $184 | 0.00% | +53 | New |
| Ronald Blue Trust, Inc. | 40 | $138 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 6 | $21 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Sugarloaf Wealth Management, LLC | – | – | – | – | Not filed |